About Tri-Service General Hospital
三軍總醫院，成立於1946年的中華民國軍醫院。1983年正式成為國防醫學院之教學醫院。目前是中華民國唯一「醫學中心」級的國軍醫院。除對中華民國國軍官兵及眷屬提供醫療服務和因應國防和軍事需求的醫學研究外，也以「三軍總醫院附設民眾診療服務處」的名義對一般大眾提供醫療服務。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Tri-Service General Hospital
45
Boehringer Ingelheim
12
National Health Research Institutes, Taiwan
7
Baxalta now part of Shire
6
EMD Serono Research & Development Institute, Inc.
6
Hoffmann-La Roche
6
Janssen Research & Development, LLC
6
National Taiwan University Hospital
6
PhytoHealth Corporation
5
Takeda
5
Athenex, Inc.
4
Clinical Trials at Tri-Service General Hospital
During the past decade, Tri-Service General Hospital conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 41 clinical trials were completed, i.e. on
average, 25.5% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 22 clinical trials were completed. i.e. 43.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
1996-05-01
Completed
342
Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
2003-11-01
2008-07-01
Completed
505
Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke
2005-09-01
2008-12-01
Terminated
277
A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)
2003-07-01
Completed
860
Efficacy and Safety of Tiotropium Inhalation Capsules and Atrovent MDI in Patients With Chronic Obstructive Pulmonary Disease (COPD)
2002-09-01
2003-10-01
Completed
132
A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma
Terminated
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)
2006-10-01
2011-06-01
Unknown status
134
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tri-Service General Hospital" #1 sponsor was "Tri-Service General Hospital" with 45 trials, followed by "Boehringer Ingelheim" with 12 trials
sponsored, "National Health Research Institutes, Taiwan" with 7 trials sponsored, "Baxalta now part of Shire" with 6 trials sponsored and "EMD Serono Research & Development Institute, Inc."
with 6 trials sponsored. Other sponsors include 147 different institutions and
companies that sponsored additional 98 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tri-Service General Hospital"
#1 collaborator was "Tri-Service General Hospital" with 13 trials as a collaborator, "China Medical University Hospital" with 7 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 6 trials as a collaborator, "Taipei Veterans General Hospital, Taiwan" with 6 trials as a collaborator and "Chang Gung Memorial Hospital" with 5 trials as a collaborator. Other collaborators include 111 different institutions and companies that were
collaborators in the rest 89 trials.
Clinical Trials Conditions at Tri-Service General Hospital
According to Clinical.Site data, the most researched conditions in "Tri-Service General Hospital" are
"Carpal Tunnel Syndrome" (15 trials), "Schizophrenia" (7 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Gastric Cancer" (5 trials) and "Hemophilia A" (5 trials). Many other conditions were trialed in "Tri-Service General Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tri-Service General Hospital
Most popular intervention types in "Tri-Service General Hospital" are "Drug" (160 trials), "Device" (28 trials), "Biological" (24 trials), "Procedure" (15 trials) and "Other" (12 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (21 trials), "Carboplatin" (8 trials), "Cisplatin" (6 trials), "Pemetrexed" (6 trials) and "Normal saline" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Tri-Service General Hospital
The vast majority of trials in "Tri-Service General Hospital" are
209 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.
Clinical Trials Status at Tri-Service General Hospital
Currently, there are 67 active trials in "Tri-Service General Hospital".
1 are not yet recruiting,
42 are recruiting,
23 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 121 completed trials in Tri-Service General Hospital,
1 suspended trials,
and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Tri-Service General Hospital, 34 "Phase 1"
clinical trials were conducted, 49 "Phase 2" clinical
trials and 75 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 16 trials, and there were
also 46 trials that are defined as “Not Applicable".